# First-in-human Study of 10-1074-LS Alone and in Combination With 3BNC117-LS

> **NCT03554408** · PHASE1 · COMPLETED · sponsor: **Rockefeller University** · enrollment: 77 (actual)

## Conditions studied

- Human Immunodeficiency Virus

## Interventions

- **DRUG:** 10-1074-LS
- **DRUG:** 10-1074-LS
- **DRUG:** 3BNC117-LS
- **DRUG:** 3BNC117-LS

## Key facts

- **NCT ID:** NCT03554408
- **Lead sponsor:** Rockefeller University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-20
- **Primary completion:** 2021-02-04
- **Final completion:** 2021-02-04
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2021-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03554408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03554408, "First-in-human Study of 10-1074-LS Alone and in Combination With 3BNC117-LS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03554408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*